Glutoshine-TH Injection Combipack contains Glutathione 600 mg, a potent antioxidant widely used for its detoxifying and skin-lightening properties. Glutathione is a tripeptide composed of glutamine, cysteine, and glycine, playing a critical role in cellular protection against oxidative stress by neutralizing free radicals and reactive oxygen species. This injection formulation is indicated for the management of conditions associated with oxidative damage, including chronic liver diseases, neurodegenerative disorders, and certain metabolic dysfunctions. Additionally, Glutoshine-TH is employed in dermatological therapies aimed at reducing hyperpigmentation, melasma, and uneven skin tone by inhibiting tyrosinase activity, thereby decreasing melanin synthesis. Administered via intramuscular or intravenous injection, the combipack provides a convenient dosing regimen to ensure optimal bioavailability and therapeutic efficacy. The use of Glutoshine-TH should be guided by a healthcare professional, considering patient-specific factors and potential contraindications such as hypersensitivity to glutathione or related compounds. Common adverse effects are generally mild and may include injection site reactions or transient gastrointestinal discomfort. Regular monitoring during treatment is recommended to assess clinical response and detect any adverse events promptly. Glutoshine-TH Injection Combipack offers a reliable and effective option for patients requiring antioxidant therapy and skin depigmentation under medical supervision.